CompletedPhase 3

Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis

Mexico72 participantsStarted 2023-03-01

Plain-language summary

To guide the administration of intravenous albumin by lung ultrasound in decompensated cirrhosis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Older than 18 years. * Decompensated cirrhosis * Indication for intravenous albumin use Exclusion Criteria: * Development of variceal hemorrage before the administration of albumin, respiratory failure previous to albumin use, or the presence of hepatocellular carcinoma

What they're measuring

Overall mortality at 30 days

Timeframe: 30 days

Trial details

NCT IDNCT07072572

SponsorCentro Medico Issemym

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-14

View on ClinicalTrials.gov More Cirrhosis trials